New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+PENFILL Novolog Mix 70/30 Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…

The post New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 PENFILL appeared first on DrugPatentWatch.

Comments are closed.